Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu K Arun

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Current Opinion in Obstetrics & Gynecology|December 16, 2014
Genetic risk assessment for breast and gynecological malignanciesJessica L Profato, Banu K Arun
Annals of Surgical Oncology|January 27, 2023
ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline TestingBrittany L Murphy, Banu K Arun
The Breast Journal|July 23, 2020
Clinical implications of breast cancer tumor genomic testingSenthil Damodaran, Quinne C Sember, Banu K Arun
The Oncologist|May 5, 2017
Systemic Treatment Strategies for Patients with Hereditary Breast Cancer SyndromesAmanda Parkes, Banu K Arun, Jennifer K Litton
Future Oncology (London, England)|March 13, 2010
Clinical application of breast cancer risk assessment modelsKaylene Ready, Jennifer K Litton, Banu K Arun
Cancer|December 22, 2017
The changing landscape of hereditary cancer genetic testingRachel D Webster, Jessica L Ross, Banu K Arun
Cancer|May 29, 2015
Reply to BRCA2-associated pancreatic cancer and current screening guidelinesJennifer K Litton, Jeffrey H Lee, Banu K Arun
Therapeutic Advances in Medical Oncology|May 17, 2012
Exemestane in the prevention settingJennifer Keating Litton, Therese B Bevers, Banu K Arun
JCO Global Oncology|January 11, 2024
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and ASana Al Sukhun, Bogda Koczwara, Sarah Temin, et al.
Cancer|December 22, 2017
Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issueBanu K Arun, Angelica M Gutierrez Barrera, Naoto T Ueno
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Current Opinion in Obstetrics & Gynecology|December 16, 2014
Genetic risk assessment for breast and gynecological malignanciesJessica L Profato, Banu K Arun
Annals of Surgical Oncology|January 27, 2023
ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline TestingBrittany L Murphy, Banu K Arun
The Breast Journal|July 23, 2020
Clinical implications of breast cancer tumor genomic testingSenthil Damodaran, Quinne C Sember, Banu K Arun
The Oncologist|May 5, 2017
Systemic Treatment Strategies for Patients with Hereditary Breast Cancer SyndromesAmanda Parkes, Banu K Arun, Jennifer K Litton
Future Oncology (London, England)|March 13, 2010
Clinical application of breast cancer risk assessment modelsKaylene Ready, Jennifer K Litton, Banu K Arun
Cancer|December 22, 2017
The changing landscape of hereditary cancer genetic testingRachel D Webster, Jessica L Ross, Banu K Arun
Cancer|May 29, 2015
Reply to BRCA2-associated pancreatic cancer and current screening guidelinesJennifer K Litton, Jeffrey H Lee, Banu K Arun
Therapeutic Advances in Medical Oncology|May 17, 2012
Exemestane in the prevention settingJennifer Keating Litton, Therese B Bevers, Banu K Arun
JCO Global Oncology|January 11, 2024
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and ASana Al Sukhun, Bogda Koczwara, Sarah Temin, et al.
Cancer|December 22, 2017
Reply to Diagnosis of patients with inflammatory breast cancer is a problematic issueBanu K Arun, Angelica M Gutierrez Barrera, Naoto T Ueno
Pageof 16